Use this dropdown to select your preferred language.
With $15 billion in net sales in 2022, we are the world’s leading pure-play consumer health company by revenue. Kenvue became a fully independent company following its listing on the NYSE in May 2023. Throughout a history spanning over 135 years, we have been a part of consumers’ daily rituals and in the moments that matter most. Today, Kenvue touches the lives of approximately 1.2 billion people in 165 countries and regions.
At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than a century, we’ve been at the forefront of research, bringing forward medicines, vaccines and innovative health solutions for the world’s most challenging diseases.
GLP is a leading, global enterprise-focused company delivering solutions across the core areas of logistics & supply chain, digital infrastructure, and energy transition. The company has a deep presence in China, where its services have become integral to supporting the high-quality development of the local economy.
Covestro is one of the world’s leading manufacturers of high-quality plastics and their components. With its innovative products, processes and methods, the company helps enhance sustainability and the quality of life in many areas. The company, based in Leverkusen, Germany, is committed to becoming fully circular and helping to make the circular economy a global guiding principle.
GEA is one of the world’s largest systems suppliers for the food, beverage and pharmaceutical sectors. Our portfolio includes machinery and high-tech plants as well as advanced process technology, components and comprehensive services for tomorrow’s food and beverage assortment. Used across diverse industries, they enhance the sustainability and efficiency of production processes globally.
作为全球领先的高端智能制造及工业互联网服务商，工业富联（全称：富士康工业互联网股份有限公司，股票代码：601138）坚持“数据驱动、绿色发展”的战略方向，业务已实现对数字经济产业五大类——云及边缘计算、工业互联网、智能家居、5G及网络通讯设备、智能手机及智能穿戴设备的全覆盖，在产品、技术以及全球市占率方面极具优势。
自2018年上市以来，公司依托于数字经济新基建的发展机遇，推动“高端智能制造+工业互联网”的四大核心业务高质量发展，实现产品技术的持续创新，公司业绩稳步增长。受益于AI算力需求强劲增长带动公司盈利能力提升，2024年全年营业收入6091.35亿元，同比增长27.88%；归母净利润232.16亿元，同比增长10.34%，营收利润均创新高。
Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top investors in research and development, the company focuses on developing innovative therapies that can improve and extend lives in areas of high unmet medical need.
Founded in 1987, Merit Medical Systems, Inc. is a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Merit employs approximately 7,100 people worldwide with facilities.
About Takeda
Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetics and Hematology, Neuroscience, and Gastroenterology.
QuidelOrtho Corporation (NASDAQ: QDEL) (“QuidelOrtho”) announced completion of the transaction combining Quidel Corporation (“Quidel”) and Ortho Clinical Diagnostics Holdings plc (“Ortho”), creating QuidelOrtho, a leading in vitro diagnostics company. The new company, headquartered in San Diego, California, generated more than $2.8 billion in 2024 and has approximately 7,000 employees.
Amer Sports is a global group of the world’s most recognized and respected sports and outdoor brands.
Amer Sports brands are loved and trusted by millions. Our brands include: Arc’teryx, Salomon, Wilson, PeakPerformance, Atomic, etc.
Elevating the world through sport is our purpose. Our purpose and values unite us across brands and geographies, unlocking our collective power to grow and succeed together.
Chiesi provides AIR, CARE, and RARE therapeutic solutions for a broad range of lung diseases in every step of life, serving millions of patients and families, helping them improve their quality of life.
In line with Chiesi Group’s sustainable development strategy, Chiesi China is also committed to ‘business as a force for good’, striving to create a positive impact on the local environment and communities while operating business in China.